Screener
Acadia Pharmaceuticals ACAD Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Interest and other receivables | 15,688 | 26,774 |
| Inventory | 32,372 | 34,670 |
| Prepaid expenses and other current assets | 69,369 | 59,526 |
| Total current assets | 1,224,545 | 1,062,113 |
| Property and equipment, net | 17,107 | 7,511 |
| Operating lease right-of-use assets | 69,424 | 47,354 |
| Intangible assets, net | 103,448 | 108,893 |
| Restricted cash | 7,846 | 7,845 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's total current assets?
- Acadia Pharmaceuticals (ACAD) reported total current assets of $1.22B in Q2 2026.
- How has Acadia Pharmaceuticals's total current assets changed year-over-year?
- Acadia Pharmaceuticals's total current assets increased by 27.5% year-over-year, from $960.55M to $1.22B.
- What is the long-term trend for Acadia Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's total current assets has grown at a 8.2% compound annual growth rate (CAGR), from $717.62M to $1.06B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Acadia Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude